Cargando…
Cancer drug resistance induced by EMT: novel therapeutic strategies
Over the last decade, important clinical benefits have been achieved in cancer patients by using drug-targeting strategies. Nevertheless, drug resistance is still a major problem in most cancer therapies. Epithelial-mesenchymal plasticity (EMP) and tumour microenvironment have been described as limi...
Autores principales: | De Las Rivas, Javier, Brozovic, Anamaria, Izraely, Sivan, Casas-Pais, Alba, Witz, Isaac P., Figueroa, Angélica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241801/ https://www.ncbi.nlm.nih.gov/pubmed/34003341 http://dx.doi.org/10.1007/s00204-021-03063-7 |
Ejemplares similares
-
Site‐specific metastasis: A cooperation between cancer cells and the metastatic microenvironment
por: Izraely, Sivan, et al.
Publicado: (2020) -
Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis
por: Moshe, Adi, et al.
Publicado: (2018) -
Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression
por: Adir, Orit, et al.
Publicado: (2023) -
Inter-Tumor Heterogeneity—Melanomas Respond Differently to GM-CSF-Mediated Activation
por: Moshe, Adi, et al.
Publicado: (2020) -
ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis
por: Izraely, Sivan, et al.
Publicado: (2017)